Biomarkers in acute respiratory distress syndrome
- 1 February 2014
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Critical Care
- Vol. 20 (1), 47-55
- https://doi.org/10.1097/mcc.0000000000000048
Abstract
The article provides an overview of efforts to identify and validate biomarkers in acute respiratory distress syndrome (ARDS) and a discussion of the challenges confronting researchers in this area. Although various putative biomarkers have been investigated in ARDS, the data have been largely disappointing and the 'troponin' of ARDS remains elusive. Establishing a relationship between measurable biological processes and clinical outcomes is vital to advancing clinical trials in ARDS and expanding our arsenal of treatments for this complex syndrome. This article summarizes the current status of ARDS biomarker research and provides a framework for future investigation.Keywords
This publication has 92 references indexed in Scilit:
- The acute respiratory distress syndromeJCI Insight, 2012
- Plasma angiopoietin-2 in clinical acute lung injuryCritical Care Medicine, 2012
- ANGPT2 Genetic Variant Is Associated with Trauma-associated Acute Lung Injury and Altered Plasma Angiopoietin-2 Isoform RatioAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Functional Disability 5 Years after Acute Respiratory Distress SyndromeThe New England Journal of Medicine, 2011
- Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injuryCritical Care Medicine, 2011
- Acute Lung Injury in Patients With Traumatic Injuries: Utility of a Panel of Biomarkers for Diagnosis and PathogenesisJournal Of Trauma-Injury Infection and Critical Care, 2010
- Genetic variants in the angiopoietin-2 gene are associated with increased risk of ARDSIntensive Care Medicine, 2009
- Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injuryIntensive Care Medicine, 2008
- From evidence to clinical practice: Effective implementation of therapeutic hypothermia to improve patient outcome after cardiac arrest*Critical Care Medicine, 2006
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001